Inbiome
PrivateLast Round
Series A
Apr 1, 2026
Total Funding Raised
$16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inbiome operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Series A round in April 2026.
Inbiome is a biotechnology company that has developed a patented Molecular Culture technology, which uses machine learning and chemistry for rapid bacterial diagnostics and microbiome analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inbiome Comparables
Compare Inbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OCEAN Dx | 78% | |
| Pattern Bioscience | 77% | |
| bioMérieux | 69% |
For institutional investors. Book with your work email.
Inbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2026 | ||||
| Grant | Jan 11, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Slingshot Ventures | Series A |
| NATO Innovation Fund | Series A |
| Voima Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$16M round completed.
- Jan 22, 2026
Monthly visitors grew 789% MoM, reaching 7.5K.
For institutional investors. Book with your work email.
Inbiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inbiome's valuation, stock price, and market status.
Is Inbiome a public or private company?
Inbiome is a private company.
What is the current stock price of Inbiome?
Inbiome is a private company, so its shares have no public market price. Caplight tracks Inbiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inbiome worth (valuation)?
Valuation information for Inbiome is not publicly available.
Can I buy Inbiome stock?
Inbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inbiome's last funding round?
Inbiome's most recent funding round was Series A on April 1, 2026.
Who are the main investors in Inbiome?
Key investors in Inbiome include European Innovation Council Fund, Slingshot Ventures, NATO Innovation Fund.
Will Inbiome IPO soon?
No public IPO plans have been announced for Inbiome.
How can I track Inbiome secondary market activity?
Caplight tracks bids, offers, and trades in Inbiome's shares on secondary markets.